Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$179.3m reported value -5.0% vs Q1 2026
37positions
58.8%in top 10
1 new 4 added 0 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MEIRAGTX HLDGS PLC COM MGTX MGTX 1,250,000 $16.9m9.42% 9.42% UnchangedShares held: Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 1.2m, Q2 2026 1.2m
2 SPROTT PHYSICAL GOLD TR UNIT PHYS PHYS 387,055 $11.7m6.51% 6.51% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 387.1k, Q2 2026 387.1k
3 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 5,475,516 $11.7m6.50% 6.50% UnchangedShares held: Q3 2025 5.5m, Q4 2025 5.5m, Q1 2026 5.5m, Q2 2026 5.5m
4 OCULAR THERAPEUTIX INC COM OCUL OCUL 1,150,400 $11.3m6.30% 6.30% AddedShares held: Q3 2025 600.4k, Q4 2025 600.4k, Q1 2026 600.4k, Q2 2026 1.2m +550.0k +550,000 91.6%
5 ROYAL GOLD INC COM RGLD RGLD 52,750 $10.5m5.87% 5.87% UnchangedShares held: Q3 2025 9.0k, Q4 2025 52.8k, Q1 2026 52.8k, Q2 2026 52.8k
6 ENTERA BIO LTD SHS ENTX ENTX 5,881,879 $10.4m5.81% 5.81% UnchangedShares held: Q3 2025 5.9m, Q4 2025 5.9m, Q1 2026 5.9m, Q2 2026 5.9m
7 NUVATION BIO INC COM CL A NUVB NUVB 1,598,591 $9.1m5.06% 5.06% AddedShares held: Q3 2025 1.0m, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.6m +100.0k +100,000 6.7%
8 AGNICO EAGLE MINES LTD COM AEM AEM 52,750 $8.2m4.56% 4.56% UnchangedShares held: Q3 2025 52.8k, Q4 2025 52.8k, Q1 2026 52.8k, Q2 2026 52.8k
9 SEABRIDGE GOLD INC COM COM 317,003 $8.2m4.55% 4.55% UnchangedShares held: Q3 2025 317.0k, Q4 2025 317.0k, Q1 2026 317.0k, Q2 2026 317.0k
10 KINROSS GOLD CORP COM KGC KGC 320,000 $7.6m4.22% 4.22% UnchangedShares held: Q3 2025 410.0k, Q4 2025 410.0k, Q1 2026 320.0k, Q2 2026 320.0k
11 OR ROYALTIES INC. COM SHS OR OR 225,000 $7.1m3.97% 3.97% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 225.0k, Q2 2026 225.0k
12 SSR MINING IN COM SSRM SSRM 245,000 $6.9m3.86% 3.86% UnchangedShares held: Q3 2025 0, Q4 2025 245.0k, Q1 2026 245.0k, Q2 2026 245.0k
13 FRANCO NEV CORP COM FNV FNV 32,000 $6.7m3.72% 3.72% UnchangedShares held: Q3 2025 25.0k, Q4 2025 25.0k, Q1 2026 32.0k, Q2 2026 32.0k
14 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $5.7m3.18% 3.18% UnchangedShares held: Q3 2025 13.0k, Q4 2025 13.0k, Q1 2026 13.0k, Q2 2026 13.0k
15 CENTERRA GOLD INC COM CGAU CGAU 359,000 $5.7m3.18% 3.18% UnchangedShares held: Q3 2025 497.4k, Q4 2025 497.4k, Q1 2026 359.0k, Q2 2026 359.0k
16 ELICIO THERAPEUTICS INC COM ELTX ELTX 1,211,957 $4.7m2.64% 2.64% AddedShares held: Q3 2025 630.9k, Q4 2025 630.9k, Q1 2026 630.9k, Q2 2026 1.2m +581.0k +581,042 92.1%
17 ABIVAX SA SPONSORED ADS ABVX ABVX 35,000 $4.7m2.60% 2.60% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 35.0k
18 PAN AMERN SILVER CORP COM PAAS PAAS 100,035 $4.5m2.50% 2.50% UnchangedShares held: Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 100.0k, Q2 2026 100.0k
19 SPROTT PHYSICAL SILVER TR TR UNIT PSLV PSLV 222,160 $4.2m2.34% 2.34% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 222.2k, Q2 2026 222.2k
20 TRIPLE FLAG PRECIOUS METAL COM TFPM TFPM 115,000 $3.4m1.92% 1.92% UnchangedShares held: Q3 2025 58.8k, Q4 2025 58.8k, Q1 2026 115.0k, Q2 2026 115.0k
21 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 485,515 $3.0m1.67% 1.67% UnchangedShares held: Q3 2025 62.7k, Q4 2025 236.0k, Q1 2026 485.5k, Q2 2026 485.5k
22 GOLD ROYALTY CORP COMMON SHARES GROY GROY 1,000,000 $2.8m1.54% 1.54% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 1.0m
23 NEW PAC METALS CORP COM NEWP NEWP 485,000 $1.9m1.09% 1.09% UnchangedShares held: Q3 2025 485.0k, Q4 2025 485.0k, Q1 2026 485.0k, Q2 2026 485.0k
24 ISHARES TR US AER DEF ETF ITA ITA 7,650 $1.9m1.03% 1.03% UnchangedShares held: Q3 2025 7.7k, Q4 2025 7.7k, Q1 2026 7.7k, Q2 2026 7.7k
25 PHILIP MORRIS INTL INC COM PM PM 10,000 $1.8m1.01% 1.01% UnchangedShares held: Q3 2025 10.0k, Q4 2025 10.0k, Q1 2026 10.0k, Q2 2026 10.0k
26 COEUR MNG INC COM NEW CDE CDE 96,132 $1.6m0.87% 0.87% UnchangedShares held: Q3 2025 96.1k, Q4 2025 96.1k, Q1 2026 96.1k, Q2 2026 96.1k
27 ALAMOS GOLD INC NEW COM CL A AGI AGI 50,000 $1.5m0.85% 0.85% UnchangedShares held: Q3 2025 50.0k, Q4 2025 50.0k, Q1 2026 50.0k, Q2 2026 50.0k
28 WHEATON PRECIOUS METALS CORP COM WPM WPM 12,500 $1.4m0.78% 0.78% UnchangedShares held: Q3 2025 12.5k, Q4 2025 12.5k, Q1 2026 12.5k, Q2 2026 12.5k
29 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $1.1m0.61% 0.61% UnchangedShares held: Q3 2025 2.2k, Q4 2025 2.2k, Q1 2026 2.2k, Q2 2026 2.2k
30 ELEMENTAL RTY CORP COM NEW ELE ELE 50,000 $873.0k0.49% 0.49% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 50.0k, Q2 2026 50.0k
31 VERSAMET ROYALTIES CORP COM NEW VMET VMET 66,621 $820.7k0.46% 0.46% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 66.6k, Q2 2026 66.6k
32 DAKOTA GOLD CORP COM DC DC 122,921 $523.6k0.29% 0.29% UnchangedShares held: Q3 2025 122.9k, Q4 2025 122.9k, Q1 2026 122.9k, Q2 2026 122.9k
33 AMRIZE LTD SHS AMRZ AMRZ 9,175 $489.0k0.27% 0.27% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 9.2k, Q2 2026 9.2k
34 ALTIMMUNE INC COM NEW ALT ALT 160,000 $486.4k0.27% 0.27% UnchangedShares held: Q3 2025 1.1m, Q4 2025 1.1m, Q1 2026 160.0k, Q2 2026 160.0k
35 PHARMING GROUP NV SPON ADS PHAR PHAR 4,091 $56.8k0.03% 0.03% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.1k, Q2 2026 4.1k +34 +34 0.8%
36 Orgenesis, Inc. COM COM 50,623 $20.8k0.01% 0.01% UnchangedShares held: Q3 2025 50.6k, Q4 2025 50.6k, Q1 2026 50.6k, Q2 2026 50.6k
37 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 2,328,602 $150.00% 0.00% UnchangedShares held: Q3 2025 895.3k, Q4 2025 2.3m, Q1 2026 2.3m, Q2 2026 2.3m

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
CARDIOL THERAPEUTICS INC CRDL CRDL 100,000 $135.0k100.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08